Janice Schierling, LSCSW, TLAC Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 601 E Center St Apt 27, Inman, KS 67546 Phone: 620-585-6372 |
News Archive
Tangent Inc., today announced the Medix T22, a medical grade, point-of-care terminal with a sharp and clear 22-inch wide-screen TFD display.
Genzyme Corporation announced today that Japan's Ministry of Health, Labour and Welfare has approved Synvisc® (hylan G-F 20; 3 x 2 mL), indicated for the treatment of osteoarthritis of the knee. Reimbursement has been obtained and publicized by Japan's Central Social Insurance Medical Council.
New research by scientists at the University of Pittsburgh provides an unprecedented level of resolution and insight into disturbances in cortical GABAergic microcircuits, which are thought to underlie cognitive impairments in schizophrenia.
A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular events.
› Verified 7 days ago